NUBAD, LLC

Company Information
Address 900 B W FARIS RD
GREENVILLE, SC, 29605-4255

http://www.nubadllc.com

Information

DUNS: 831389122

# of Employees: 3


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. Screening the Ribosome for New Target Sites

    Amount: $650,000.00

    DESCRIPTION provided by applicant Nucleic acids are avenues for drug design both as therapeutics and as targets Here we propose to establish new methods for identifying antibiotic ribosome target ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  2. Aminoglycosides with reduced ototoxicity

    Amount: $600,000.00

    PROJECT SUMMARY Aminoglycosides are one of the cheapest and well known antibiotics in clinical use for over years but one of the major limitations in their use is their ototoxicity We are develo ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  3. Development of Aminoglycoside-Nucleic Acid Conjugates for Inactivation of an Antibiotic Resistance-Conferring Aminoglycoside Sensing Riboswitch

    Amount: $464,380.00

    DESCRIPTION provided by applicant The world is rapidly heading towards a pre andapos s scenario when it comes to fighting infectious disease Antimicrobial resistance is a growing problem on a ...

    SBIRPhase I2015Department of Health and Human Services
  4. A Rapid assay for RNA targeted drugs: Instrumentation Supplement

    Amount: $1,430,141.00

    DESCRIPTION provided by applicant Some of the most significant therapies that treat disease target nucleic acids Drugs that target nucleic acid include cancer drugs antibiotics and antivirals C ...

    STTRPhase II2014Department of Health and Human Services National Institutes of Health
  5. Development of Peptide Antibiotic Nucleic Acids

    Amount: $595,355.00

    DESCRIPTION provided by applicant One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and p ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
  6. Targeting RNA conformation for drug development

    Amount: $294,583.00

    DESCRIPTION (provided by applicant): One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and pr ...

    STTRPhase I2012Department of Health and Human Services
  7. A novel assay for RNA targeted drugs

    Amount: $285,505.00

    DESCRIPTION (provided by applicant): NUBAD, LLC is a drug discovery company devoted to identifying therapeutic agents that target nucleic acids. This project is designed to synthesize and characterize ...

    STTRPhase I2011Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government